Cargando…
A forecasting model for drug utilization and expenditure integrating a Cellular Automata model with the Budget Impact Analysis approach. Preliminary results
Autores principales: | Joppi, Roberta, Cinconze, Elisa, Demattè, Luca, Guseo, Renato, Jommi, Claudio, Mortarino, Cinzia, Pase, Daniela, Poggiani, Chiara, Roggeri, Alessandro, Roggeri, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603620/ http://dx.doi.org/10.1186/2052-3211-8-S1-P9 |
Ejemplares similares
-
Overt hepatic encephalopathy in Italy: clinical outcomes and healthcare costs
por: Roggeri, Daniela Paola, et al.
Publicado: (2015) -
Economic impact of the use of rifaximin 550 mg twice daily for the treatment of overt hepatic encephalopathy in Italy
por: Roggeri, Daniela Paola, et al.
Publicado: (2017) -
Outcomes and costs of treating chronic obstructive pulmonary disease with inhaled fixed combinations: the Italian perspective of the PATHOS study
por: Roggeri, Alessandro, et al.
Publicado: (2014) -
Inhalation errors due to device switch in patients with chronic obstructive pulmonary disease and asthma: critical health and economic issues
por: Roggeri, Alessandro, et al.
Publicado: (2016) -
Impact of hospitalizations for bronchiolitis in preterm infants on long-term health care costs in Italy: a retrospective case-control study
por: Roggeri, Daniela Paola, et al.
Publicado: (2016)